BioCentury
ARTICLE | Clinical News

Incyte Pharmaceuticals Inc. regulatory update

May 2, 1994 7:00 AM UTC

IPI (Palo Alto) this week is to receive U.S. Patent No. 5,308,834 covering the use of bactericidal/permeability-increasing protein, its lead biotherapeutic, and fragments thereof, in the treatment of ...